Strategy to recognize and initiate treatment of chronic heart failure in primary care (STRETCH): a cluster randomized trial

BMC Cardiovascular Disorders

Frans H Rutten¹  Marcel AJ Landman¹  Henk van der Hoeven²  Alexander Limburg²  Arno W Hoes¹  Evelien ES van Riet¹ 

[1] Julius Center for Health Sciences and Primary care, University Medical Center Utrecht, PO Box 85500, 3508 AB, Utrecht, The Netherlands;Diakonessenhuis Zeist, Zeist, The Netherlands

关键词: Cluster randomized trial;    Primary care;    Elderly;    Treatment;    Diagnosis;    Heart failure;   

Others  :  855550
DOI  :  10.1186/1471-2261-14-1

 received in 2013-12-18, accepted in 2013-12-30,  发布年份 2014

【 摘 要 】

Background

Most patients with heart failure are diagnosed and managed in primary care, however, underdiagnosis and undertreatment are common. We assessed whether implementation of a diagnostic-therapeutic strategy improves functionality, health-related quality of life, and uptake of heart failure medication in primary care.

Methods/Design

A selective screening study followed by a single-blind cluster randomized trial in primary care. The study population consists of patients aged 65 years or over who presented themselves to the general practitioner in the previous 12 months with shortness of breath on exertion. Patients already known with established heart failure, confirmed by echocardiography, are excluded. Diagnostic investigations include history taking, physical examination, electrocardiography, and serum N-terminal pro B-type natriuretic peptide levels. Only participants with an abnormal electrocardiogram or an N-terminal pro B-type natriuretic peptide level exceeding the exclusionary cutpoint for non-acute onset heart failure (> 15 pmol/L (≈ 125 pg/ml)) will undergo open-access echocardiography. The diagnosis of heart failure (with reduced or preserved ejection fraction) is established by an expert panel consisting of two cardiologists and a general practitioner, according to the criteria of the European Society of Cardiology guidelines.

Patients with newly established heart failure are allocated to either the 'care as usual’ group or the 'intervention’ group. Randomization is at the level of the general practitioner. In the intervention group general practitioners receive a single half-day training in heart failure management and the use of a structured up-titration scheme. All participants fill out quality of life questionnaires at baseline and after six months of follow-up. A six-minute walking test will be performed in patients with heart failure. Information on medication and hospitalization rates is extracted from the electronic medical files of the general practitioners.

Discussion

This study will provide information on the prevalence of unrecognized heart failure in elderly with shortness of breath on exertion, and the randomized comparison will reveal whether management based on a half-day training of general practitioners in the practical application of an up-titration scheme results in improvements in functionality, health-related quality of life, and uptake of heart failure medication in heart failure patients compared to care as usual.

Trial registration

ClinicalTrials.gov NCT01202006

【 授权许可】

   
2014 van Riet et al.; licensee BioMed Central Ltd.

【 图 表 】

【 参考文献 】

• [1]Schocken DD, Benjamin EJ, Fonarow GC, Krumholz HM, Levy D, Mensah GA, et al.: Prevention of heart failure: a scientific statement from the American heart association councils on epidemiology and prevention, clinical cardiology, cardiovascular nursing, and high blood pressure research; quality of care and outcomes research interdisciplinary working group; and functional genomics and translational biology interdisciplinary working group. Circulation 2008, 117:2544-2565.
• [2]Levy D, Kenchaiah S, Larson MG, Benjamin EJ, Kupka MJ, Ho KK, et al.: Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002, 347:1397-1402.
• [3]Roger VL, Weston SA, Redfield MM, Hellermann-Homan JP, Killian J, Yawn BP, et al.: Trends in heart failure incidence and survival in a community-based population. JAMA 2004, 292:344-350.
• [4]Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Strömberg A, et al.: ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European society of cardiology; developed in collaboration with the heart failure association of the ESC (HFA) and endorsed by the European society of intensive care medicine (ESICM). Eur J Heart Fail 2008, 10:933-989.
• [5]Paulus WJ: Novel strategies in diastolic heart failure. Heart 2010, 96:1147-1153.
• [6]Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM: Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006, 355:251-259.
• [7]Mosterd A, Hoes AW: Clinical epidemiology of heart failure. Heart 2007, 93:1137-1146.
• [8]Remes J, Miettinen H, Reunanen A, Pyorala K: Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 1991, 12:315-321.
• [9]Wheeldon NM, MacDonald TM, Flucker CJ, McKendrick AD, McDevitt DG, Struthers AD: Echocardiography in chronic heart failure in the community. Q J Med 1993, 86:17-23.
• [10]Rutten FH, Cramer MJ, Grobbee DE, Sachs AP, Kirkels JH, Lammers JW, et al.: Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J 2005, 26:1887-1894.
• [11]Cleland JG, Cohen-Solal A, Aguilar JC, Dietz R, Eastaugh J, Follath F, et al.: Management of heart failure in primary care (the IMPROVEMENT of heart failure programme): an international survey. Lancet 2002, 360:1631-1639.
• [12]Rutten FH, Grobbee DE, Hoes AW: Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice. Eur J Heart Fail 2003, 5:337-344.
• [13]Rostagno C, Olivo G, Comeglio M, Boddi V, Banchelli M, Galanti G, et al.: Prognostic value of 6-minute walk corridor test in patients with mild to moderate heart failure: comparison with other methods of functional evaluation. Eur J Heart Fail 2003, 5:247-252.
• [14]Rasekaba T, Lee AL, Naughton MT, Williams TJ, Holland AE: The six-minute walk test: a useful metric for the cardiopulmonary patient. Intern Med J 2009, 39:495-501.
• [15]Spertus J, Peterson E, Conard MW, Heidenreich PA, Krumholz HM, Jones P, et al.: Monitoring clinical changes in patients with heart failure: a comparison of methods. Am Heart J 2005, 150:707-715.
• [16]Lamberts H, Oskam SK, Okkes IM: the clinical relationship between symptoms and the final diagnosis in general practice, determined by means of posterior probabilities calculated on the basis of the transition project. Ned Tijdschr Geneeskd 2005, 149:2566-2572.
• [17]McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, et al.: ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European society of cardiology: developed in collaboration with the heart failure association (HFA) of the ESC. Eur J Heart Fail 2012, 14:803-869.
• [18]Rose GA, Blackburn H: Cardiovascular survey methods. Geneva: World Health Organisation; 1982.
• [19]Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al.: Recommendations for chamber quantification: a report from the American society of Echocardiography’s guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European association of echocardiography, a branch of the European society of cardiology. J Am Soc Echocardiogr 2005, 18:1440-1463.
• [20]Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, et al.: Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009, 22:107-133.
• [21]ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories: ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002, 166:111-117.
• [22]Rutten FH, Walma EP, Kruizinga GI, Bakx HCA, Van Lieshout J: NHG-standaard hartfalen. Huisarts Wet 2005, 48(2):64-76.
• [23]Paulus WJ, Tschope C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, et al.: How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the heart failure and echocardiography associations of the European society of cardiology. Eur Heart J 2007, 28:2539-2550.
• [24]Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation 1977, 55:613-618.
• [25]Pollentier B, Irons SL, Benedetto CM, Dibenedetto AM, Loton D, Seyler RD, et al.: Examination of the six minute walk test to determine functional capacity in people with chronic heart failure: a systematic review. Cardiopulm Phys Ther J 2010, 21:13-21.
• [26]Aaronson NK, Muller M, Cohen PD, Essink-Bot ML, Fekkes M, Sanderman R, et al.: Translation, validation, and norming of the dutch language version of the SF-36 health survey in community and chronic disease populations. J Clin Epidemiol 1998, 51:1055-1068.
• [27]McHorney CA, Ware JE Jr, Raczek AE: The MOS 36-item short-form health survey (SF-36): II psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993, 31:247-263.
• [28]EuroQol Group: EuroQol--a new facility for the measurement of health-related quality of life. Health Policy 1990, 16:199-208.
• [29]Brooks R: EuroQol: the current state of play. Health Policy 1996, 37:53-72.
• [30]Oostenbrink JB, Koopmanschap MA, Rutten FF: Standardisation of costs: the dutch manual for costing in economic evaluations. Pharmacoeconomics 2002, 20:443-454.
• [31]Health Insurance Council: Dutch guidelines for pharmacoeconomic research. Amstelveen: Ziekenfondsraad; 1999.